HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong.

AbstractOBJECTIVE:
To determine the risk factors associated with and to describe the clinical course of tuberculosis (TB) in patients with systemic lupus erythematosus (SLE).
METHODS:
Clinical features of patients with TB during the 1-year period prior to the diagnosis of TB were compared with controls.
RESULTS:
Of the 526 SLE patients, 57 (11%) had TB. Extra-pulmonary or miliary TB occurred in 67%. Patients with TB were more likely to have organic brain syndrome, vasculitis, and nephritis: and they were also more likely to have received intravenous 'pulse' methylprednisolone or high cumulative dose of prednisolone. The cumulative dose of prednisolone and presence of nephritis were independent risk factors for the development of TB using multivariate regression analysis.
CONCLUSIONS:
There is a high prevalence of TB, especially extra-pulmonary diseases, among SLE patients in Hong Kong. High cumulative dose of corticosteroid and lupus nephritis are important risk factors for the development of TB.
AuthorsLai-Shan Tam, Edmund K Li, Shiu-Man Wong, Cheuk-Chun Szeto
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 31 Issue 5 Pg. 296-300 ( 2002) ISSN: 0300-9742 [Print] Norway
PMID12455821 (Publication Type: Journal Article)
Chemical References
  • Glucocorticoids
  • Prednisolone
Topics
  • Adolescent
  • Adult
  • Aged
  • Asian Continental Ancestry Group
  • Female
  • Glucocorticoids (therapeutic use)
  • Hong Kong (epidemiology)
  • Humans
  • Immunocompromised Host
  • Lupus Erythematosus, Systemic (complications, drug therapy, epidemiology, physiopathology)
  • Male
  • Middle Aged
  • Nephritis (complications, epidemiology)
  • Prednisolone (therapeutic use)
  • Risk Factors
  • Tuberculosis, Miliary (complications, epidemiology, physiopathology)
  • Tuberculosis, Pulmonary (complications, epidemiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: